These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3308892)

  • 1. The mechanism of 2-deoxy-glucose-induced insulin secretion in the mouse.
    Karlsson S; Bood M; Ahrén B
    J Auton Pharmacol; 1987 Jun; 7(2):135-44. PubMed ID: 3308892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of 2-deoxy-glucose-induced glucagon secretion by muscarinic and alpha-adrenoceptor blockade in the mouse.
    Karlsson S; Ahrén B
    Diabetes Res Clin Pract; 1987; 3(4):239-42. PubMed ID: 2887409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism for the inhibitory action of 2-deoxy-glucose on thyroid hormone secretion in the mouse.
    Ahrén B; Hedner P
    Neuroendocrinology; 1989 May; 49(5):471-5. PubMed ID: 2725841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin and glucagon secretion in swimming mice: effects of autonomic receptor antagonism.
    Karlsson S; Ahrén B
    Metabolism; 1990 Jul; 39(7):724-32. PubMed ID: 1973257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptide YY antagonizes beta-adrenergic-stimulated release of insulin in dogs.
    Greeley GH; Lluis F; Gomez G; Ishizuka J; Holland B; Thompson JC
    Am J Physiol; 1988 Apr; 254(4 Pt 1):E513-7. PubMed ID: 2895586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. alpha2A-adrenoceptor antagonism increases insulin secretion and synergistically augments the insulinotropic effect of glibenclamide in mice.
    Fagerholm V; Scheinin M; Haaparanta M
    Br J Pharmacol; 2008 Jul; 154(6):1287-96. PubMed ID: 18493247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neither adrenergic nor cholinergic antagonists in the central nervous system affect 2-deoxy-D-glucose(2-DG)-induced hyperglycemia.
    Iguchi A; Gotoh M; Matsunaga H; Yatomi A; Uemura K; Miura H; Kunoh Y; Tamagawa T; Sakamoto N
    Brain Res; 1990 Mar; 510(2):321-5. PubMed ID: 1970507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of adrenergic-blocking or -stimulating agents on plasma growth hormone, immunoreactive insulin, and blood free fatty acid levels in man.
    Imura H; Kato Y; Ikeda M; Morimoto M; Yawata M
    J Clin Invest; 1971 May; 50(5):1069-79. PubMed ID: 4928263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholinergic effect of 2-deoxy-D-glucose on plasma glucagon levels in conscious rats.
    Haito K; Takeda A; Kagawa S; Shimizu S; Matsuoka A
    Horm Metab Res; 1984 Dec; 16 Suppl 1():110-3. PubMed ID: 6398250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of 2-deoxy-D-glucose on plasma somatostatin levels in conscious dogs.
    Wasada T; Dobbs RE; Harris V; Unger RH
    Endocrinology; 1981 Apr; 108(4):1222-7. PubMed ID: 6110537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autonomic nervous system control of glucagon secretion during neuroglucopenia.
    Asplin CM; Werner PL; Halter JB; Hollander PM; Palmer JP
    Endocrinology; 1983 May; 112(5):1585-9. PubMed ID: 6339209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of autonomic blockade by methylatropine and optical isomers and propranolol on plasma insulin levels in the basal state and after stimulation.
    Ahrén B; Lundquist I
    Acta Physiol Scand; 1981 May; 112(1):57-63. PubMed ID: 7025578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of neural intrapancreatic non-cholinergic non-adrenergic mechanisms to glucose-induced insulin release in the isolated rat pancreas.
    Weigert N; Dollinger M; Schmid R; Schusdziarra V
    Diabetologia; 1992 Dec; 35(12):1133-9. PubMed ID: 1478364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Monolayer culture of pancreatic islet cells of the adult rat: effect of 2-deoxy-2-fluoroglucose].
    Aoki M; Kagawa S; Yamamura T; Matsuoka A; Utsunomiya J
    Nihon Naibunpi Gakkai Zasshi; 1988 Feb; 64(2):109-18. PubMed ID: 3286298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastrin releasing peptide (GRP): effects on basal and stimulated insulin and glucagon secretion in the mouse.
    Pettersson M; Ahrén B
    Peptides; 1987; 8(1):55-60. PubMed ID: 3554168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of alpha-adrenoceptor blockade by phentolamine on basal and stimulated insulin secretion in the mouse.
    Ahrén B; Lundquist I
    Acta Physiol Scand; 1985 Oct; 125(2):211-7. PubMed ID: 2866660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of two cholecystokinin variants, CCK-39 and CCK-8, on basal and stimulated insulin secretion.
    Ahrén B; Lundquist I
    Acta Diabetol Lat; 1981; 18(4):345-56. PubMed ID: 6277122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. beta-Adrenergic insulin release and adrenergic innervation of mouse pancreatic islets.
    Lundquist I; Ericson LE
    Cell Tissue Res; 1978 Oct; 193(1):73-85. PubMed ID: 363270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abolition of dopaminergic insulin secretion by beta-adrenergic antagonism.
    Cyrus J; Stagner J; Samols E
    Endocrinology; 1982 Jul; 111(1):214-8. PubMed ID: 6123430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperglycaemic effect of glucagon administered intracerebroventricularly in the rat.
    Marubashi S; Tominaga M; Katagiri T; Yamatani K; Yawata Y; Hara M; Sasaki H
    Acta Endocrinol (Copenh); 1985 Jan; 108(1):6-10. PubMed ID: 2857512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.